Strides Arcolab is currently trading at Rs. 754.55, up by 2.25 points or 0.30% from its previous closing of Rs. 752.30 on the BSE.
The scrip opened at Rs. 751.90 and has touched a high and low of Rs. 768.00 and Rs. 747.00 respectively. So far 38650 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 794.00 on 18-Jul-2012 and a 52 week low of Rs. 276.25 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 794.00 and Rs. 735.00 respectively. The current market cap of the company is Rs. 4408.10 crore.
The promoters holding in the company stood at 28.27% while Institutions and Non-Institutions held 54.03% and 17.70% respectively.
French Development Financing Institution, Proparco has invested $12.5 million for 20% stake in Strides Arcolabs’ African front end arm, valuing the African operations at about $60 million. The funds raised will be used to create additional manufacturing infrastructure in key markets in Africa and to build a regional company with the philosophy of 'In Africa for Africa.’
Strides Africa has strategically organized its front end African business into a Strategic Business Unit. The business operates in the branded generics and OTC generics segments and has footprints in 23 Sub Saharan African countries, excluding South Africa. The company has been present in Africa and contributing to the improvement of healthcare by manufacturing and marketing a wide range of lifesaving antibiotics etc.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1531.05 |
| Dr. Reddys Lab | 6428.05 |
| Cipla | 1482.30 |
| Zydus Lifesciences | 1093.45 |
| Lupin | 1637.60 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
